CAS 1063331-94-1

Formula: C17H16ClN7

InChI: InChI=1S/C17H16ClN7/c1-10-8-11(2)25(23-10)17-21-15(14-16(22-17)24(3)9-19-14)20-13-6-4-12(18)5-7-13/h4-9H,1-3H3,(H,20,21,22)

InChI key: DVQOPNIPUIOXHU-UHFFFAOYSA-N

SMILES: CC1=CC(=NN1C2=NC(=C3C(=N2)N(C=N3)C)NC4=CC=C(C=C4)Cl)C

N-(4-Chlorophenyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-9-methyl-9H-purin-6-amine

CAS: 1063331-94-1

Formula: C₁₇H₁₆ClN₇

Purity: 95%

Color and Shape: Solid

Molecular weight: 353.8088

Ref: IN-DA0096LO

NS13001

CAS: 1063331-94-1

NS13001

Formula: C₁₇H₁₆ClN₇

Purity: ≥98%

Molecular weight: 353.81

Ref: 54-BUP05712

NS13001

CAS: 1063331-94-1

NS13001, an oral SK channel modulator, shows promise for SCA2 therapy; EC50: 1.8 µM (SK2), 0.14 µM (SK3).

Formula: C₁₇H₁₆ClN₇

Purity: 99.55%

Color and Shape: White Solid

Molecular weight: 353.809

Ref: TM-T16345

N-(4-Chlorophenyl)-2-(3,5-Dimethyl-1H-Pyrazol-1-Yl)-9-Methyl-9H-Purin-6-Amine

CAS: 1063331-94-1

N-(4-Chlorophenyl)-2-(3,5-Dimethyl-1H-Pyrazol-1-Yl)-9-Methyl-9H-Purin-6-Amine

Formula: C₁₇H₁₆ClN₇

Purity: 95%

Molecular weight: 353.81

Ref: 54-OR1025830

NS13001

CAS: 1063331-94-1

N-(4-Chlorophenyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-9-methyl-9H-purin-6-amine

Formula: C₁₇H₁₆ClN₇

Purity: 95%

Molecular weight: 353.81

Ref: IN-DG303839

N-(4-Chlorophenyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-9-methyl-9H-purin-6-amine

CAS: 1063331-94-1

Formula: C₁₇H₁₆ClN₇

Purity: 95%

Molecular weight: 353.81

Ref: 10-F498455

N-(4-Chlorophenyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-9-methyl-9H-purin-6-amine

Controlled Product

CAS: 1063331-94-1

Formula: C₁₇H₁₆ClN₇

Color and Shape: Neat

Molecular weight: 353.809

Ref: TR-N110535

NS13001

CAS: 1063331-94-1

NS13001 is a small molecule that has been shown to induce apoptotic cell death in leukemia cells. It binds to the cytochrome p450 protein, which is an important regulator of intracellular calcium. NS13001 binds to calmodulin and alters calcium signaling, leading to the activation of pro-apoptotic genes. This drug also increases the cytosolic calcium concentration by activating the ryanodine receptor, which results in cerebellar Purkinje neurons degeneration. NS13001 has been shown to be effective against lymphocytic leukemia cells that express activated caspase 3 and microglia cells.

Formula: C₁₇H₁₆ClN₇

Purity: Min. 95%

Molecular weight: 353.81 g/mol

Ref: 3D-NSB33194